Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Price to Earnings (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) Price to Earnings stood at 83.35 in Q1 2026, down 96.5% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Price to Earnings (2025 - 2026) Analysis & Trends

For FY2025, Xeris Biopharma Holdings' Price to Earnings came in at 2355.22.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 83.35
Dec 31, 2025 2,355.22
API Access

Xeris Biopharma Holdings Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=XERS&period=max&api_key=YOUR_API_KEY